Anti-Obesity Drugs: A Review about Their Effects and Safety

  title={Anti-Obesity Drugs: A Review about Their Effects and Safety},
  author={Jun Goo Kang and Cheol Young Park},
  booktitle={Diabetes & metabolism journal},
The current recommendations for the treatment of obese people include increased physical activity and reduced calories intake. When the behavioral approach is not sufficient, a pharmacologic treatment is recommended. In past years, numerous drugs have been approved for the treatment of obesity; however, most of them have been withdrawn from the market because of their adverse effects. In fact, amphetamine, rimonabant and sibutramine licenses have been withdrawn due to an increased risk of… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 7 times. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 101 extracted citations

Macrocytic Anemia and Thrombocytopenia Induced by Orlistat

International journal of endocrinology and metabolism • 2013
View 6 Excerpts
Highly Influenced


Publications referenced by this paper.
Showing 1-10 of 61 references

Valvular heart disease associated with fenfluramine-phentermine.

The New England journal of medicine • 1997
View 4 Excerpts
Highly Influenced

BLOSSOM Clinical Trial Group. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial

MC Fidler, M Sanchez, +4 authors CM Anderson
J Clin Endocrinol Metab 2011;96:3067-77 • 2011

New drug targets for the treatment of obesity.

Clinical pharmacology and therapeutics • 2011
View 2 Excerpts

Similar Papers

Loading similar papers…